GlaxoSmithKline plc And Reckitt Benckiser plc Aim To Unlock Value

The pharma sector is in upheaval, with massive deals making weekly headlines and companies taking evasive action to pre-empt the advances of predators. But will separating drugs businesses from consumer healthcare divisions really reap dividends for shareholders? Owain Bennallack takes a look at GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and Reckitt Benckiser (LSE: RB)

To find out the names and reasons behind five shares in the FTSE 100 that our top analysts have highlighted in our special report "5 Shares To Retire On, simply click here to have it delivered completely FREE to your inbox!

Owain Bennallack has no position in any shares mentioned. The Motley Fool recommends Reckitt Benckiser Group, Unilever, and Unilever. The Motley Fool owns shares of Unilever.